MedTrace Logo

Ablation vs Resection of Colorectal Cancer Liver Metastases

NCT05129787 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2026-02-12

No results posted yet for this study

Summary

230 patients with colorectal cancer liver metastases will be randomly assigned to resection or thermal ablation.

Conditions

  • Colorectal Cancer Metastatic

Interventions

PROCEDURE

Surgical resection

Resection of metastasis

PROCEDURE

Thermal ablation

Ablation of metastasis

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Bjørn Edwin, Professor · Head of clinical research, The Intervention Centre, Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-16
Primary Completion
2026-10-23
Completion
2030-10-23

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129787 on ClinicalTrials.gov